Balasa Dinverno & Foltz LLC Abbott Laboratories Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 16,558 shares of ABT stock, worth $1.69 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

16,558

Previous 15,411 7.44%

Holding current value

$1.69 Million

Previous $1.67 Million 4.3%

% of portfolio

0.1%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $110,983 - $128,498	1,147 Added 7.44%	16,558 $1.6 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $63,997 - $77,352	627 Added 4.24%	15,411 $1.67 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $55,413 - $67,573	-486 Reduced 3.18%	14,784 $1.75 Million
Q4 2021 Jan 26, 2022	SELL	$115.53 - $141.46 $24,145 - $29,565	-209 Reduced 1.35%	15,270 $2.15 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $77,812 - $86,083	-667 Reduced 4.13%	15,479 $1.83 Million

Q2 2021 Jul 23, 2021	SELL	$105.79 - $124.53 $120,283 - $141,590	-1,137 Reduced 6.58%	16,146 $1.87 Million
Q1 2021 Apr 29, 2021	BUY	$108.84 - $128.23 $609,395 - $717,959	5,599 Added 47.92%	17,283 $2.07 Million
Q4 2020 Jan 26, 2021	BUY	$105.0 - $114.42 $236,145 - $257,330	2,249 Added 23.84%	11,684 $1.28 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $49,852 - $60,541	544 Added 6.12%	9,435 $1.03 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $332,543 - $425,614	-4,343 Reduced 32.82%	8,891 $813,000
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $52,517 - $76,794	-836 Reduced 5.94%	13,234 $1.04 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $14,131 - $15,732	-180 Reduced 1.26%	14,070 $1.22 Million
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $91,660 - $99,388	1,120 Added 8.53%	14,250 $1.19 Million
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $21,718 - $25,330	298 Added 2.32%	13,130 $1.1 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $21,190 - $25,619	320 Added 2.56%	12,832 $1.03 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $74,017 - $83,850	1,129 Added 9.92%	12,512 $905,000
Q3 2018 Oct 24, 2018	BUY	$60.81 - $73.36 $6,385 - $7,702	105 Added 0.93%	11,383 $835,000
Q2 2018 Aug 01, 2018	BUY	$57.57 - $63.54 $1,439 - $1,588	25 Added 0.22%	11,278 $688,000
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $16,993 - $19,213	-302 Reduced 2.61%	11,253 $674,000
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $8,481 - $9,080	158 Added 1.39%	11,555 $659,000
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $547,739 - $611,335	11,397	11,397 $608,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Abbott Laboratories Transaction History